The first pick would be in the pharma space, we are seeing quite good momentum here today, so pharma you can see Syngene which is giving you a good fresh breakout above 700 level so I think it is looking quite positive from current levels to test higher targets of 720, 725.
Nifty eyes consolidation, key support at 23,800: Sudeep Shah of SBI Securities
“Nifty IT is witnessing an outperformance, and this could witness further strength in the coming few sessions. After marking a high of 43,645 on September